Filter by keyword: Filter by year:

“Marching-in” on Patent Rights: The Biden Administration’s Effort to Lower Pharmaceutical Prices

April 14, 2024

On December 7, 2023, the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) issued a notice-and-comment period for their new

Cryptocurrency under the Gavel: The Implications of SEC Lawsuits against Binance and Coinbase

March 3, 2024

In June 2023, the U.S. Securities and Exchange Commission (SEC) initiated legal action against two of the largest and most influential crypto asset

Regulating Prescription Drug Promotion on Social Media

January 26, 2024

Digital platforms have revolutionized how information is disseminated to consumers. In the United States, the typical user

AI's Regulatory Challenge: Avoiding the Pitfalls of Past Mistakes

December 18, 2023

Artificial intelligence (AI) has returned to the forefront of public discourse, sparked by the AI Safety

NIS2 - Europe’s Strengthened Cybersecurity Regime

November 6, 2023

The European Parliamentary Research Service describes the Network and Information Security (NIS) Directive as the first